SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Therapeutics market size is expected to reach US$ 2991.4 million by 2029, .....
SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. The global Acromegaly Drugs market size is expected to reach US$ 2991.4 million by 2029, growing.....
SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Hemin market size is expected to reach US$ 56 million by 2029, growing at a CAGR of 1.8% from 202.....
SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Panhematin market size is expected to reach US$ 56 million by 2029, growing at a CAGR of 1.8.....
SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Hemin Drugs market size is expected to reach US$ 56 million by 2029, growing at a CAGR of 1.8% fr.....
SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Panhematin Drugs market size is expected to reach US$ 56 million by 2029, growing at a CAGR .....
SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. The global Swedish Porphyria market size is ex.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
